Escitalopram oxalate is the active ingredient in Lexapro, a widely prescribed antidepressant that belongs to the selective serotonin reuptake inhibitor (SSRI) class. It is FDA-approved for treating major depressive disorder in adults and adolescents aged 12 to 17, and for generalized anxiety disorder in adults. If you’ve seen this name on a prescription label or pharmacy printout, it’s the full chemical name for what most people simply call escitalopram.
Why the Name Says “Oxalate”
The “oxalate” part refers to the salt form of the drug. Escitalopram on its own is the active compound, but pharmaceutical manufacturers pair it with oxalic acid to create a stable salt that dissolves reliably and absorbs consistently in the body. This is standard practice for many medications. The oxalate portion has no therapeutic effect of its own.
The “es” at the beginning of escitalopram is also meaningful. The drug is a refined version of an older antidepressant called citalopram (Celexa). Citalopram is a mixture of two mirror-image molecules, but only one of those molecules, the S-enantiomer, actually works on the brain’s serotonin system. Escitalopram is purely that active mirror image, which makes it over 100 times more potent at blocking serotonin reuptake than the inactive half. In practical terms, this means you get the therapeutic effect at a lower dose with less inactive material in your system.
How It Works in the Brain
Escitalopram targets a protein called the serotonin transporter, which acts like a vacuum cleaner on nerve endings, pulling serotonin back into the cell after it has been released. By blocking this transporter, the drug allows serotonin to remain active in the gaps between nerve cells for longer, strengthening the brain’s serotonin signaling.
What makes escitalopram slightly unusual among SSRIs is that it binds to the serotonin transporter in two places at once. It attaches to the main binding site (where all SSRIs work) and also to a secondary spot on the same transporter. That secondary attachment slows down the rate at which the drug detaches from the main site, essentially locking it in place longer. This dual-binding mechanism is thought to give escitalopram a more consistent effect on serotonin levels compared to some other SSRIs.
What It Feels Like Starting Out
After taking a dose, blood levels of the drug peak at about 5 hours. The medication has a relatively long half-life of 27 to 32 hours, which means it leaves the body slowly and only needs to be taken once a day. Steady-state levels, the point where the amount entering your system matches the amount leaving, are reached within about one week of daily dosing. Most people don’t feel the full antidepressant or anti-anxiety benefit for several weeks, though side effects can show up sooner.
The most common side effects in clinical trials were nausea and insomnia. Among people taking it for depression, 15% experienced nausea (compared to 7% on placebo) and 9% had insomnia (versus 4% on placebo). The numbers were slightly higher for people treated for generalized anxiety: 18% reported nausea and 12% reported insomnia. These side effects are typically most noticeable in the first week or two and often ease as the body adjusts.
Important Safety Concerns
All SSRIs, including escitalopram, carry an FDA boxed warning about an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults during the early phase of treatment. This doesn’t mean the medication causes suicidal behavior in most people, but close monitoring is important during the first weeks, especially for younger patients. Families and caregivers are advised to watch for unusual changes in mood or behavior during this period.
Serotonin syndrome is another risk, though it’s rare when escitalopram is used on its own. It becomes a real concern when the drug is combined with other medications that also raise serotonin levels. Symptoms typically appear within hours of adding a new drug or increasing a dose. Early signs include agitation, restlessness, rapid heart rate, heavy sweating, diarrhea, and muscle twitching. Severe cases can involve high fever, seizures, and irregular heartbeat. This is a medical emergency.
Drug and Supplement Interactions
Certain combinations with escitalopram are particularly risky. Older antidepressants called MAOIs can trigger dangerous spikes in blood pressure, even if the MAOI was stopped weeks earlier. Medications that affect heart rhythm can compound escitalopram’s own mild effect on heartbeat, potentially causing an irregular rhythm.
St. John’s wort, an herbal supplement sometimes used for mild depression, should not be taken alongside escitalopram. It raises serotonin levels through a separate mechanism and significantly increases the risk of serotonin syndrome. If you’re switching from St. John’s wort to a prescription antidepressant, or vice versa, a washout period is needed.
Stopping Escitalopram Safely
Discontinuation symptoms are a well-documented issue with SSRIs, and escitalopram is no exception. Stopping abruptly can cause dizziness, irritability, nausea, sensory disturbances (sometimes described as “brain zaps”), and flu-like feelings. Standard guidelines have traditionally recommended tapering over 2 to 4 weeks, but research suggests these short tapers often provide minimal benefit over abrupt cessation and many patients still struggle with withdrawal.
More recent evidence points to a slower, more gradual approach. Tapering over months, with progressively smaller dose reductions toward the end, appears to be significantly more effective at minimizing withdrawal symptoms. The reason is that the drug’s effect on serotonin transporters doesn’t decrease in a straight line as the dose drops. Small reductions at already-low doses can cause disproportionately large changes in brain chemistry, so the final steps of tapering need to be the smallest and slowest.